Helical tomotherapy in patients with breast cancer and complex treatment volumes
- 21 April 2011
- journal article
- Published by Springer Nature in Clinical and Translational Oncology
- Vol. 13 (4) , 268-274
Abstract
To describe early clinical results of tomotherapy treatment in patients with breast cancer and complex treatment volumes. Ten patients were treated with tomotherapy between January 2009 and March 2010. Treatment planning objectives were to cover at least 95% of the planning target volume with the 95% isodose; to have a minimum dose of 90% and a maximum dose of 105%. All treatments included daily CT/megavoltage image guidance. Acute toxicity was recorded weekly. Six patients were treated because constraints were not accomplished for heart, lung or contralateral breast in a previous three-dimensional conformal plan; two for preexisting cardiac or pulmonary disease, and two more for bilateral breast irradiation. Treatment volumes included the whole breast in the majority of patients, as well as the supraclavicular and the internal mammary chain nodes when indicated. Most patients were older than 50 years, and had an early breast cancer, with positive oestrogen receptors, negative HER2 expression and a poorly differentiated, infiltrating ductal carcinoma. The majority of patients had received neoadjuvant chemotherapy associated to breastconserving surgery and adjuvant hormonotherapy. Median homogeneity index was 1.09; median coverage index was 0.81. Median V20Gy and V10Gy for ipsilateral lung was 20% and 37.1% respectively. Median V25 and V35 for heart was 15% and 4% respectively. Median dose for contralateral breast was 7 Gy. Skin acute toxicity was grade 1 in 41.7% and grade 2 in 58.3%. Tomotherapy is a technique capable of delivering a well tolerated treatment with high homogeneity and coverage indexes and high capabilities for sparing the organs at risk in patients with anatomically complex breast cancer, bilateral breast cancer, indication for internal mammary chain node irradiation, cardiac toxicity derived from chemotherapy, or preexisting cardiac or pulmonary disease. Further studies are required to evaluate local control and late toxicity.Keywords
This publication has 43 references indexed in Scilit:
- Feasibility of Postmastectomy Treatment With Helical TomoTherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2010
- A phantom model demonstration of tomotherapy dose painting delivery, including managed respiratory motion without motion managementPhysics in Medicine & Biology, 2010
- Simultaneous integrated boost in breast conserving treatment of breast cancer: A dosimetric comparison of helical tomotherapy and three-dimensional conformal radiotherapyRadiotherapy and Oncology, 2010
- Breast Intensity-Modulated Radiation Therapy Reduces Time Spent With Acute Dermatitis for Women of All Breast Sizes During RadiationInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2009
- Helical tomotherapy for locoregional irradiation including the internal mammary chain in left-sided breast cancer: Dosimetric evaluationRadiotherapy and Oncology, 2009
- Technique alternatives for breast radiation oncology: Conventional radiation therapy to tomotherapyJournal of Medical Physics, 2009
- Dosimetric consequences of the shift towards computed tomography guided target definition and planning for breast conserving radiotherapyRadiation Oncology, 2008
- Évaluation nationale de la tomothérapie hélicoïdale : description des indications, des contraintes de dose et des seuils de repositionnementCancer/Radiothérapie, 2007
- Questions d'actualité : schéma général d'élaboration des protocoles de tomothérapie hélicoïdale pour chaque localisationCancer/Radiothérapie, 2006
- Risk of Cardiac Death After Adjuvant Radiotherapy for Breast CancerJNCI: Journal of the National Cancer Institute, 2005